9846: Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI)

DCP-001: Use of a Clinical Trial Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program

EAY131 (MATCH): Molecular Analysis for Therapy Choice

S1609: DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (For patients that did not have a match to a molecularly guided therapy on EAY131 – MATCH or who progressed on molecularly-matched therapy and have no further molecularly-matched treatment recommendations)

TAPUR: The Targeted Agent and Profiling Utilization Registry Study